Wellington Management Group’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $165M | Sell |
3,805,710
-1,680,044
| -31% | -$73M | 0.03% | 396 |
|
|
2025
Q1 | $205M | Buy |
5,485,754
+968,391
| +21% | +$36.2M | 0.04% | 341 |
|
|
2024
Q4 | $205M | Sell |
4,517,363
-297,037
| -6% | -$13.5M | 0.04% | 363 |
|
|
2024
Q3 | $283M | Buy |
4,814,400
+1,267,451
| +36% | +$74.5M | 0.05% | 317 |
|
|
2024
Q2 | $140M | Buy |
3,546,949
+1,277,052
| +56% | +$50.3M | 0.02% | 463 |
|
|
2024
Q1 | $151M | Buy |
2,269,897
+678,419
| +43% | +$45.1M | 0.03% | 451 |
|
|
2023
Q4 | $44.4M | Buy |
1,591,478
+4,749
| +0.3% | +$132K | 0.01% | 743 |
|
|
2023
Q3 | $33M | Buy |
+1,586,729
| New | +$33M | 0.01% | 817 |
|